Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium-derivatives and succinyl-choline-esters
- PMID:13229430
Item in Clipboard
Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium-derivatives and succinyl-choline-esters
E J ARIENS et al. Arch Int Pharmacodyn Ther..
Display options
Format
Display options
Format
No abstract available
Similar articles
- CYCLIC ANALOGS AND CONGENERS OF SUCCINYL DICHOLINE.MCCARTHY JF, CANNON JG, BUCKLEY JP, KINNARD WJ.MCCARTHY JF, et al.J Med Chem. 1964 Jan;7:72-5. doi: 10.1021/jm00331a016.J Med Chem. 1964.PMID:14186030No abstract available.
- [STUDIES ON THE DIFFERENTIATION OF THE TYPE OF NEUROMUSCULAR BLOCK].KATSURASHIMA T.KATSURASHIMA T.Tohoku Igaku Zasshi. 1962 Aug;66:183-200.Tohoku Igaku Zasshi. 1962.PMID:14059179Japanese.No abstract available.
- COMPARATIVE ACTIVITIES OF MALEYL, FUMARYL, AND SUCCINYL DICHOLINE. A CORRECTION OF THE LITERATURE.MCCARTHY JF, CANNON JG, BUCKLEY JP.MCCARTHY JF, et al.J Pharm Sci. 1963 Dec;52:1168-71. doi: 10.1002/jps.2600521215.J Pharm Sci. 1963.PMID:14088968No abstract available.
- [NEW MUSCLE RELAXANTS].SATO M, KAYA K.SATO M, et al.Nihon Ishikai Zasshi. 1963 Dec 1;50:841-7.Nihon Ishikai Zasshi. 1963.PMID:14096725Review.Japanese.No abstract available.
- Muscle relaxants: advances in the last decade.Siker ES, Wolfson B, Schaner PJ.Siker ES, et al.Clin Anesth. 1969;3:415-57.Clin Anesth. 1969.PMID:4330726Review.No abstract available.
Cited by
- Neuromuscular blocking properties of some bistropinium esters.HAINING CG, JOHNSTON RG.HAINING CG, et al.Br J Pharmacol Chemother. 1962 Apr;18(2):275-86. doi: 10.1111/j.1476-5381.1962.tb01407.x.Br J Pharmacol Chemother. 1962.PMID:13903721Free PMC article.
- Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.Cawston EE, Miller LJ.Cawston EE, et al.Br J Pharmacol. 2010 Mar;159(5):1009-21. doi: 10.1111/j.1476-5381.2009.00489.x. Epub 2009 Nov 18.Br J Pharmacol. 2010.PMID:19922535Free PMC article.Review.
- A modification of receptor theory. 1956.Stephenson RP.Stephenson RP.Br J Pharmacol. 1997 Feb;120(4 Suppl):106-20; discussion 103-5. doi: 10.1111/j.1476-5381.1997.tb06784.x.Br J Pharmacol. 1997.PMID:9142399Free PMC article.No abstract available.
- The action of 2-O-Methyltyrosine-oxytocin on the rat and rabbit uterus: effect of some experimental conditions on change from agonism to antagonism.Krejcí I, Polácek I, Rudinger J.Krejcí I, et al.Br J Pharmacol Chemother. 1967 Aug;30(3):506-17. doi: 10.1111/j.1476-5381.1967.tb02157.x.Br J Pharmacol Chemother. 1967.PMID:6050496Free PMC article.No abstract available.
- Dose-response curves for angiotensin II and synthetic analogues in three types of smooth muscle: existence of different forms of receptor sites for angiotensin II.Papadimitriou A, Worcel M.Papadimitriou A, et al.Br J Pharmacol. 1974 Feb;50(2):291-7. doi: 10.1111/j.1476-5381.1974.tb08575.x.Br J Pharmacol. 1974.PMID:4371902Free PMC article.